JP2003528887A5 - - Google Patents

Download PDF

Info

Publication number
JP2003528887A5
JP2003528887A5 JP2001571713A JP2001571713A JP2003528887A5 JP 2003528887 A5 JP2003528887 A5 JP 2003528887A5 JP 2001571713 A JP2001571713 A JP 2001571713A JP 2001571713 A JP2001571713 A JP 2001571713A JP 2003528887 A5 JP2003528887 A5 JP 2003528887A5
Authority
JP
Japan
Prior art keywords
vaccine according
peptide
human cytomegalovirus
vaccine
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001571713A
Other languages
English (en)
Japanese (ja)
Other versions
JP5602332B2 (ja
JP2003528887A (ja
Filing date
Publication date
Priority claimed from US09/534,639 external-priority patent/US6251399B1/en
Priority claimed from US09/692,170 external-priority patent/US6562345B1/en
Application filed filed Critical
Publication of JP2003528887A publication Critical patent/JP2003528887A/ja
Publication of JP2003528887A5 publication Critical patent/JP2003528887A5/ja
Application granted granted Critical
Publication of JP5602332B2 publication Critical patent/JP5602332B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001571713A 2000-03-27 2001-03-16 ヒトサイトメガロウイルスの免疫ー反応性ペプチドctlエピトープ Expired - Lifetime JP5602332B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/534,639 US6251399B1 (en) 1996-11-12 2000-03-27 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
US09/534,639 2000-03-27
US09/692,170 US6562345B1 (en) 1996-11-12 2000-10-20 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
US09/692,170 2000-10-20
PCT/US2001/008576 WO2001072782A2 (en) 2000-03-27 2001-03-16 Immuno-reactive peptide ctl epitopes of human cytomegalovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011243962A Division JP5731952B2 (ja) 2000-03-27 2011-11-07 ヒトサイトメガロウイルスの免疫ー反応性ペプチドctlエピトープ

Publications (3)

Publication Number Publication Date
JP2003528887A JP2003528887A (ja) 2003-09-30
JP2003528887A5 true JP2003528887A5 (cg-RX-API-DMAC7.html) 2007-06-28
JP5602332B2 JP5602332B2 (ja) 2014-10-08

Family

ID=27064538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001571713A Expired - Lifetime JP5602332B2 (ja) 2000-03-27 2001-03-16 ヒトサイトメガロウイルスの免疫ー反応性ペプチドctlエピトープ

Country Status (6)

Country Link
US (6) US6562345B1 (cg-RX-API-DMAC7.html)
EP (1) EP1268529A2 (cg-RX-API-DMAC7.html)
JP (1) JP5602332B2 (cg-RX-API-DMAC7.html)
AU (2) AU2001249243B2 (cg-RX-API-DMAC7.html)
CA (1) CA2401638C (cg-RX-API-DMAC7.html)
WO (1) WO2001072782A2 (cg-RX-API-DMAC7.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935675B1 (en) * 1994-07-15 2011-05-03 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20040171028A1 (en) * 1996-06-06 2004-09-02 Baker Brenda F. Phosphorous-linked oligomeric compounds and their use in gene modulation
US6632435B1 (en) * 1999-10-20 2003-10-14 City Of Hope CTL epitope analogs
US20040191260A1 (en) 2003-03-26 2004-09-30 Technion Research & Development Foundation Ltd. Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
US8022190B2 (en) 2001-06-19 2011-09-20 Technion Research & Development Foundation Ltd. Immuno-molecules containing viral proteins, compositions thereof and methods of using
AUPR593101A0 (en) * 2001-06-26 2001-07-19 Council Of The Queensland Institute Of Medical Research, The Cytomegalovirus t cell epitopes
EP1483575A2 (en) * 2002-02-28 2004-12-08 Intercell AG Methods for isolating ligands e.g. t cell epitopes
US8895020B2 (en) * 2002-04-19 2014-11-25 Washington University Single chain trimers and uses therefor
AU2003277865B2 (en) * 2002-06-25 2008-08-21 City Of Hope Adjuvant-free peptide vaccine
JP2005533855A (ja) 2002-07-24 2005-11-10 インターツェル・アクチェンゲゼルシャフト 病原性ウイルスからの別のリーディングフレームによりコードされる抗原
EP1537418A2 (en) 2002-09-13 2005-06-08 Intercell AG Method for isolating hepatitis c virus peptides
US20040072262A1 (en) * 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
AU2004224746B2 (en) 2003-03-24 2009-04-23 Valneva Austria Gmbh Improved vaccines
US7163685B2 (en) * 2003-04-16 2007-01-16 City Of Hope Human cytomegalovirus antigens expressed in MVA and methods of use
US20050232933A1 (en) * 2003-09-30 2005-10-20 Zaia John A CMV-IE1 peptides and method of use
WO2005047902A1 (en) * 2003-11-03 2005-05-26 Beckman Coulter, Inc. Solution-based methods for detecting mhc-binding peptides
US9090673B2 (en) 2003-12-12 2015-07-28 City Of Hope Synthetic conjugate of CpG DNA and T-help/CTL peptide
EP1766393A4 (en) * 2004-05-07 2008-06-18 Beckman Coulter Inc MHC-BRIDGE SYSTEM FOR DETECTION OF THE CTL-MEDIATED LYSE OF ANTIGEN-PRESENTING CELLS
EP2226332A1 (en) * 2004-06-17 2010-09-08 Beckman Coulter, Inc. Mycobacterium tuberculosis epitopes and methods of use thereof
WO2006101909A2 (en) * 2005-03-16 2006-09-28 Ischemix, Inc. Combination therapy for treating or preventing diseases
US8518697B2 (en) * 2006-04-04 2013-08-27 Washington University Single chain trimers and uses therefor
WO2007136778A2 (en) * 2006-05-19 2007-11-29 Teva Pharmaceutical Industries, Ltd. Fusion proteins, uses thereof and processes for producing same
US20080138354A1 (en) * 2006-07-21 2008-06-12 City Of Hope Cytomegalovirus vaccine
EP2155782A2 (en) 2007-03-26 2010-02-24 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
WO2009003493A2 (en) 2007-07-03 2009-01-08 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
WO2009039854A2 (en) 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
CA2728739C (en) * 2008-06-20 2017-07-11 Duke University Use of human cytomegalovirus antigens to enhance immune responses to cancer cells
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037397A1 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cmv immune monitoring
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
HRP20220519T1 (hr) 2011-06-24 2022-05-27 Nono Inc. Kombinacijska terapija ishemije
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
EP3888675A1 (en) * 2013-09-24 2021-10-06 Duke University Compositions, methods and kits for eliciting an immune response
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
EP3364981A4 (en) 2015-10-22 2019-08-07 ModernaTX, Inc. VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
EP3528821A4 (en) 2016-10-21 2020-07-01 ModernaTX, Inc. HUMAN CYTOMEGALOVIRUS VACCINE
KR20200084883A (ko) * 2017-11-06 2020-07-13 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 기존의 미생물 면역을 활용한 암 치료
CN109748952B (zh) * 2018-05-02 2020-09-15 中国药科大学 辅助性表位肽及其应用
CA3100420A1 (en) * 2018-05-18 2019-11-21 The Council Of The Queensland Institute Of Medical Research Adoptive t-cell therapy for cmv infection and cmv-associated diseases
WO2020127222A2 (en) 2018-12-17 2020-06-25 Immudex Aps Panel comprising borrelia mhc multimers
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TWI871709B (zh) 2020-06-21 2025-02-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白B(gB)多肽
US11406703B2 (en) 2020-08-25 2022-08-09 Modernatx, Inc. Human cytomegalovirus vaccine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762780A (en) 1984-04-17 1988-08-09 The Regents Of The University Of California Method and composition for screening and diagnosing "HCMV"
GB8404368D0 (en) 1984-02-20 1984-03-28 Cogent Ltd Monoclonal antibodies to human cytomegalovirus
US5075213A (en) 1984-07-27 1991-12-24 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US6207161B1 (en) * 1986-07-16 2001-03-27 City Of Hope Induction of cytolytic T-lymphocytes with cytomegalovirus polypeptides
EP0553186B1 (en) 1990-09-28 1999-09-01 Immunex Corporation Method for producing t h?-independent cytotoxic t lymphocytes
US5470730A (en) 1990-09-28 1995-11-28 Immunex Method for producing TH -independent cytotoxic T lymphocytes
AU675204B2 (en) 1992-06-25 1997-01-30 City Of Hope Induction of cytolytic T-lymphocytes with cytomegalovirus polypeptides
US5405940A (en) 1992-08-31 1995-04-11 Ludwig Institute For Cancer Research Isolated nonapeptides derived from MAGE genes and uses thereof
CN1135181A (zh) 1993-09-14 1996-11-06 Cytel有限公司 使用泛dr结合肽改变免疫应答
US5827642A (en) 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
US5635363A (en) 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
US6448389B1 (en) 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
US6156317A (en) 1996-11-12 2000-12-05 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
US6074645A (en) 1996-11-12 2000-06-13 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
FR2757169B1 (fr) 1996-12-13 1999-03-05 Inst Nat Sante Rech Med Proteine de fusion comportant tout ou partie de la proteine pp65 de cmv humain, utile notamment dans la preparation d'un vaccin
US7041442B1 (en) 1999-06-04 2006-05-09 Florian Kern Peptides for vaccinating against human CMV

Similar Documents

Publication Publication Date Title
UY25146A1 (es) Proteínas de fusión hpv comprendiendo una proteína e6, e7 o e6e7 fusionada con una proteína d de haemophilus influenzae b o derivados de la misma y composiciones para uso como vacunas que las comprenden
JP2001516569A5 (cg-RX-API-DMAC7.html)
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
CA2391843A1 (en) Hcv vaccine compositions
WO1998037095A3 (en) Recombinant pox virus for immunization against muc1 tumor-associated antigen
CA2253636A1 (en) Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
WO2002034205A3 (en) Using heat shock proteins to increase immune response
Lingnau et al. Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines
JP2002542827A5 (cg-RX-API-DMAC7.html)
CA2395499A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
RU2003103779A (ru) Экспрессионная система
WO2005007673A3 (en) Immunogenic peptides
CO4650186A1 (es) Composicion de vacuna
EP1741782A3 (en) Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
MX9801089A (es) Proteina hibrida que comprende epitopes estimulantes de celula auxiliar t y epitopes de celula b de la proteina de membrana externa mayor chlamydia trachomatis y su uso como vacuna.
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
CA2254082A1 (en) Metastatic colorectal cancer vaccine
EP1829552A3 (en) Chlamydia PMP proteins, gene sequences and uses thereof
WO2001010469A3 (en) Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
WO2002036611A3 (en) Immunomodulatory peptides derived from heat shock proteins and uses thereof
IL141443A0 (en) Vaccine comprising cytokine-induced heat shock proteins (hsp)
CA2516661A1 (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
WO2002069691A3 (en) Immunogenic hiv peptides for use as reagents and vaccines
WO2002051237A3 (en) Helicobacter proteins, nucleic acids and uses thereof